Xofluza Eiropas Savienība - latviešu - EMA (European Medicines Agency)

xofluza

roche registration gmbh - baloxavir marboxil - gripas, cilvēka - pretvīrusu līdzekļi sistēmiskai lietošanai - treatment of influenzaxofluza is indicated for the treatment of uncomplicated influenza in patients aged 1 year and above. post exposure prophylaxis of influenzaxofluza is indicated for post-exposure prophylaxis of influenza in individuals aged 1 year and above. xofluza should be used in accordance with official recommendations.